Earnings History Data for Longboard Pharmaceuticals, Inc. (LBPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel, transformative medicines for neurological diseases. Longboard Pharmaceuticals Inc. is based in SAN DIEGO.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-11-2024 PM LBPH Longboard Pharmaceuticals, Inc. 2,320 -0.63 -0.59 -0.55 Longboard Pharmaceuticals GAAP EPS of -$0.63
[11/8/2024 6:29 AM]
59.80 0.02 
(0.03%)
59.75 -0.03 
(-0.05%)
3.60 - 59.95 604,513 930,000 20,203
01-08-2024 AH LBPH Longboard Pharmaceuticals, Inc. 1,300 -0.56 -0.46 -0.65 Longboard Pharmaceuticals GAAP EPS of -$0.56
[8/2/2024 10:29 AM]
33.05 0.13 
(0.39%)
32.92 0.0 
(0.00%)
3.60 - 40.48 773,122 620,000 18,507
02-05-2024 AH LBPH Longboard Pharmaceuticals 767.00 -0.42 -0.48 0.00 Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
[5/3/2024 2:53 PM]
21.41 -1.40 
(-6.14%)
22.81 0.0 
(0.00%)
3.60 - 28.15 431,770 370,000 6,413
12-03-2024 AH LBPH Longboard Pharmaceuticals 469.00 -0.62 -0.60 0.00 Longboard Pharmaceuticals GAAP EPS of -$2.39 beats by $0.02
[3/12/2024 4:58 PM]
19.91 0.91 
(4.76%)
20.35 1.35 
(7.11%)
3.60 - 28.15 493,383 420,000 5,305
02-11-2023 PM LBPH Longboard Pharmaceuticals, Inc. 124.43 -0.55 -0.72 -0.68 Longboard Pharmaceuticals GAAP EPS of -$0.55 beats by $0.15
[11/3/2023 1:17 AM]
5.53 0.14 
(2.60%)
5.39 0.0 
(0.00%)
3.11 - 10.29 63,841 40,000 1,752
03-08-2023 PM LBPH Longboard Pharmaceuticals, Inc. 168.82 -0.65 -0.61 -0.67 Longboard Pharmaceuticals GAAP EPS of -$0.65 misses by $0.04
[8/4/2023 9:28 AM]
7.17 -0.32 
(-4.27%)
7.49 0.0 
(0.00%)
2.70 - 10.29 77,245 60,000 467
09-05-2023 AH LBPH Longboard Pharmaceuticals 208.00 -0.56 -0.59 0.00 10.05 0.56 
(5.95%)
9.49 0.0 
(0.00%)
2.70 - 10.29 170,691 160,000 10,651
02-03-2023 AH After the close
(Mar 2)
LBPH Longboard Pharmaceuticals, Inc. 107.30 -0.66 -0.63 -0.52 Longboard Pharmaceuticals reports FY 2022 results
[3/2/2023 4:35 PM]
5.15 -0.11 
(-2.09%)
5.02 -0.24 
(-4.56%)
2.70 - 6.47 9,818 30,000 500
04-08-2022 AH 4:05 PM ET
(Aug 4)
LBPH Longboard Pharmaceuticals 46.00 -0.67 -0.54 0.00 Longboard Pharmaceuticals GAAP EPS of -$0.67 misses by $0.13
[8/4/2022 5:33 PM]
3.52 -0.02 
(-0.56%)
0.0 0.0 
(0.00%)
2.84 - 11.36 1,246 0 0
05-05-2022 AH 4:05 PM ET
(May 5)
LBPH Longboard Pharmaceuticals 67.00 -0.56 -0.52 0.00 Longboard Pharmaceuticals GAAP EPS of -$0.56
[5/5/2022 5:34 PM]
4.81 0.19 
(4.11%)
0.0 0.0 
(0.00%)
3.90 - 18.50 967 0 0